OMNIS 3.0 Software released

3rd party data integration, compliance with FDA 21 CFR Part 11, client/server, and long-term support (LTS) are among the latest features of the laboratory data management platform from Metrohm

9 Dec 2022
Georgina Wynne Hughes
Editorial Assistant

Metrohm is pleased to release OMNIS 3.0, the latest version of the company’s software for laboratory data management. Features such as compliance with 21 FDA CFR part 11 (compliance package), client/server installation, 3rd party data integration, and long-term support (LTS) versions meet the requirements especially, in the regulated environment. With the release of OMNIS 3.0, all current instruments of the Metrohm Titrando family can now also be controlled by OMNIS providing for a seamless transition from Titrando to OMNIS.

OMNIS Client/Server - the networkable version of OMNIS

OMNIS Client/Server is the networkable version of OMNIS. OMNIS Client/Server helps users increase the efficiency of their laboratory enabling straightforward collaboration and central management of data, instruments, SOPs, and users. Up to 100 clients can be managed centrally in an OMNIS Client/Server network.

OMNIS 3rd Party Data Integration – connecting OMNIS to your LIMS, ERP, ELN, and more

OMNIS 3rd Party Data Integration is a secure interface based on the latest web technology. The OMNIS Web-API enables the seamless exchange of data between OMNIS and any kind of 3rd party business management software (e.g., LIMS, ERP, ELN).

OMNIS Long-Term Support (LTS) – 5 years guaranteed service and support

With OMNIS LTS, users benefit from 5 years of guaranteed service and support of their OMNIS LTS version from the release of that version. No new features are added to your OMNIS LTS version during that period guaranteeing stable system performance and minimizing the need for sophisticated re-qualification and re-validation processes.

OMNIS Compliance Package – peace of mind for the regulated environment

The OMNIS Compliance package provides a central Audit Trail for complete documentation as per the requirements of FDA 21 CFR Part 11 and Eudralex, Volume 4, Annex 11.

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>

Links

Tags